Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-25 @ 8:22 PM
Study NCT ID:
NCT00227669
Status:
COMPLETED
Last Update Posted:
2016-08-30
First Post:
2005-09-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
Sponsor:
UNICANCER
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2010-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-26
First Submit QC Date:
None
Study First Post Date:
2005-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-08-29
Last Update Post Date:
2016-08-30
Last Update Post Date Type:
ESTIMATED